CN Patent

CN116056709A — 哒嗪酮化合物

Assigned to Yifang Biotechnology Shanghai Co ltd · Expires 2023-05-02 · 3y expired

What this patent protects

本文提供了化合物和组合物，其可用于治疗或预防由甲状腺激素受体激动剂调节的疾病或病症，如非酒精性脂肪性肝炎(NASH)或非酒精性脂肪性肝病(NAFLD)。

USPTO Abstract

本文提供了化合物和组合物，其可用于治疗或预防由甲状腺激素受体激动剂调节的疾病或病症，如非酒精性脂肪性肝炎(NASH)或非酒精性脂肪性肝病(NAFLD)。

Drugs covered by this patent

Patent Metadata

Patent number
CN116056709A
Jurisdiction
CN
Classification
—
Expires
2023-05-02
Drug substance claim
No
Drug product claim
No
Assignee
Yifang Biotechnology Shanghai Co ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.